Literature DB >> 21834039

Chromosome 22q11.2 deletion syndrome in African-American patients: a diagnostic challenge.

Aravindhan Veerapandiyan1, Omar A Abdul-Rahman, Margaret P Adam, Michael J Lyons, Melanie Manning, Karlene Coleman, Lisa Kobrynski, Deeksha Taneja, Kelly Schoch, Holly H Zimmerman, Vandana Shashi.   

Abstract

Chromosome 22q11.2 deletion syndrome (22q11DS) is associated with numerous and variable clinical manifestations including conotruncal heart abnormalities, palatal anomalies, hypoparathyroidism, immune deficiency, and cognitive deficits. The clinical suspicion of this syndrome is often heightened by the presence of characteristic facial features. A previous report highlighted the under-diagnosis of this condition in African Americans, thought to be related to a paucity of typical facial features. We ascertained the largest cohort (n = 50) of African-American individuals with 22q11DS reported thus far, across five genetics centers in the United States and report on their facial and other phenotypic features. About 3/4 of our cohort has at least one dysmorphic facial feature. Auricular abnormalities, especially small ears, are the most common dysmorphic facial feature followed by nasal and ocular abnormalities. Skeletal findings are seen in about 2/3 of our cohort, higher than the typical frequency reported in 22q11DS. Cardiac anomalies, developmental delay, and palatal abnormalities are seen at a lower frequency in our cohort. Thus, it is evident that the features traditionally associated with 22q11DS are difficult to recognize in African-American individuals with this syndrome, due to both altered frequencies of major anomalies and a non-classic facial appearance. Therefore, a high index of suspicion is needed to recognize 22q11DS in African-American individuals.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21834039     DOI: 10.1002/ajmg.a.34226

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.

Authors:  S X Tang; J J Yi; M E Calkins; D A Whinna; C G Kohler; M C Souders; D M McDonald-McGinn; E H Zackai; B S Emanuel; R C Gur; R E Gur
Journal:  Psychol Med       Date:  2013-09-09       Impact factor: 7.723

2.  Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability.

Authors:  Felippe Borlot; Brigid M Regan; Anne S Bassett; D James Stavropoulos; Danielle M Andrade
Journal:  JAMA Neurol       Date:  2017-11-01       Impact factor: 18.302

3.  Elucidating the diagnostic odyssey of 22q11.2 deletion syndrome.

Authors:  Lisa D Palmer; Nancy J Butcher; Erik Boot; Kathleen A Hodgkinson; Tracy Heung; Eva W C Chow; Alina Guna; T Blaine Crowley; Elaine Zackai; Donna M McDonald-McGinn; Anne S Bassett
Journal:  Am J Med Genet A       Date:  2018-04       Impact factor: 2.802

4.  22q11.2 deletion syndrome in diverse populations.

Authors:  Paul Kruszka; Yonit A Addissie; Daniel E McGinn; Antonio R Porras; Elijah Biggs; Matthew Share; T Blaine Crowley; Brian H Y Chung; Gary T K Mok; Christopher C Y Mak; Premala Muthukumarasamy; Meow-Keong Thong; Nirmala D Sirisena; Vajira H W Dissanayake; C Sampath Paththinige; L B Lahiru Prabodha; Rupesh Mishra; Vorasuk Shotelersuk; Ekanem Nsikak Ekure; Ogochukwu Jidechukwu Sokunbi; Nnenna Kalu; Carlos R Ferreira; Jordann-Mishael Duncan; Siddaramappa Jagdish Patil; Kelly L Jones; Julie D Kaplan; Omar A Abdul-Rahman; Annette Uwineza; Leon Mutesa; Angélica Moresco; María Gabriela Obregon; Antonio Richieri-Costa; Vera L Gil-da-Silva-Lopes; Adebowale A Adeyemo; Marshall Summar; Elaine H Zackai; Donna M McDonald-McGinn; Marius George Linguraru; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2017-04       Impact factor: 2.802

5.  Ocular findings in 22q11.2 deletion syndrome: A systematic literature review and results of a Dutch multicenter study.

Authors:  Emma N M M von Scheibler; Emy S van der Valk Bouman; Myrthe A Nuijts; Noël J C Bauer; Tos T J M Berendschot; Pit Vermeltfoort; Levinus A Bok; Agnies M van Eeghen; Michiel L Houben; Thérèse A M J van Amelsvoort; Erik Boot; Michelle B van Egmond-Ebbeling
Journal:  Am J Med Genet A       Date:  2021-11-12       Impact factor: 2.578

6.  Medical genetics and genomic medicine in Rwanda.

Authors:  Annette Uwineza; Leon Mutesa
Journal:  Mol Genet Genomic Med       Date:  2015-11-08       Impact factor: 2.183

7.  Array-CGH analysis in Rwandan patients presenting development delay/intellectual disability with multiple congenital anomalies.

Authors:  Annette Uwineza; Jean-Hubert Caberg; Janvier Hitayezu; Anne Cecile Hellin; Mauricette Jamar; Vinciane Dideberg; Emmanuel K Rusingiza; Vincent Bours; Leon Mutesa
Journal:  BMC Med Genet       Date:  2014-07-12       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.